Vienna Insurance Group’s Bristol-Myers Squibb BMY Stock Holding History

Vienna Insurance Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-56,000	Closed	-$4.09M	–	37
2022 Q1	$4.09M	Hold	56,000	–	–	2.29%	19
2021 Q4	$3.49M	Hold	56,000	–	–	2.39%	22
2021 Q3	$3.31M	Hold	56,000	–	–	1.77%	25
2021 Q2	$3.74M	Hold	56,000	–	–	2.35%	19
2021 Q1	$3.54M	Buy	+56,000	New	+$3.48M	3.37%	10

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vienna Insurance Group's BMY Position: Q2 2022 in Review

Vienna Insurance Group sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 56,000 shares — an estimated $4.09M sold.

Vienna Insurance Group first reported a position in BMY in Q1 2021 and held it in 5 quarters. The position peaked at $4.09M in Q1 2022. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Vienna Insurance Group reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
Vienna Insurance Group sold 56,000 Bristol-Myers Squibb shares in Q2 2022, an estimated $4.09M.
Vienna Insurance Group first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 5 quarters.
Vienna Insurance Group's Bristol-Myers Squibb position peaked at $4.09M in Q1 2022.
2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Vienna Insurance Group's 13F filing for Q2 2022, filed 4 Sep 2024.